NBX Biosciences
Developing oral microbiome-based therapeutics for brain health and cognitive impairment
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-09
About NBX Biosciences
NBX Biosciences develops defined oral Live Biotherapeutic candidates targeting biological pathways associated with cognition, neuroinflammation and neurodegeneration. Its lead candidate, NBX-5831, is in preclinical development.
The company develops therapeutics for pharmaceutical development and welcomes collaboration with scientific and clinical partners, development partners and investors.
NBX Biosciences was founded in 2023 and is based in Montpellier, France. Its small team works across microbiology, immunology and neuroscience; no vacancy is currently open.
Product: Preclinical oral Live Biotherapeutic candidates for brain health, including lead candidate NBX-5831.
Jobs at NBX Biosciences
More biotech & pharma companies
Netris Pharma
Oncology biopharma developing anti-Netrin-1 antibodies to overcome cancer treatment resistance, spun out of Centre Léon Bérard in LyonNew on EvolcNeuro-Sys
Preclinical neuroscience research services for pharmaceutical, biotech and academic organizations developing CNS and PNS therapiesNew on EvolcNeurofit
Preclinical neuroscience research models and testing services for biopharmaceutical drug developersNew on EvolcNeuron Experts
Preclinical CRO running primary neuronal cell assays for neuropharmacology and neurodermatology companiesNew on EvolcNevezyne
Custom recombinant therapeutic protein expression and purification services for biotechnology and pharmaceutical researchersYoung companyNew on EvolcNextpharma
Contract pharmaceutical development, manufacturing and packaging for drug developers and supplement brandsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
